From Liston Street Pulse:
Shares of Omeros Corporation (OMER), a biopharmaceutical company engaged in the discovery, development and commercialization of products focused on inflammation and disorders of central nervous system, have risen sharply in trading today after the company announced that the NDA for its ophthalmology product, OMS302, has been confirmed for filing by […]
The post Omeros Corporation Shares Rise Sharply appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015